Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (4): 93-99.doi: 10.6040/j.issn.1671-7554.0.2020.1548
Previous Articles Next Articles
XIE Tonghui, CHEN Zhiqiang, CHANG Jianhua, ZHAO Danwen, XU Bowen, ZHI Xuting
CLC Number:
[1] Gupta A, Dixon E. Epidemiology and risk factors: intrahepatic cholangiocarcinoma[J]. Hepatobiliary Surg Nutr, 2017, 6(2): 101-104. [2] Zhang H, Yang T, Wu M, et al. Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management[J]. Cancer Lett, 2016, 379(2): 198-205. [3] Chun Y, Javle M. Systemic and adjuvant therapies for intrahepatic cholangiocarcinoma[J]. Cancer Control, 2017, 24(3): 1-7. [4] Rahnemai-Azar A, Weisbrod A, Dillhoff M, et al. Intrahepatic cholangiocarcinoma: current management and emerging therapies[J]. Expert Rev Gastroenterol Hepatol, 2017, 11(5): 439-449. [5] 刘连新, 尹大龙. 肝内胆管癌多学科综合治疗优化选择[J]. 中国实用外科杂志, 2020, 40(6): 680-684. LIU Xinlian, YIN Dalong. Optimal management of multidisciplinary treatment for intrahepatic chaolangiocarcinoma[J]. Chinese Journal of Practical Surgery, 2020, 40(6): 680-684. [6] Mavros M, Economopoulos K, Alexiou V, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis[J]. JAMA Surgery, 2014, 149(6): 565-574. [7] Van Dyke A, Shiels M, Jones G, et al. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013[J]. Cancer, 2019, 125(9): 1489-1498. [8] de Jong M, Nathan H, Sotiropoulos G, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment J]. J Clin Oncol, 2011, 29(23): 3140-3145. [9] Ejaz A, Cloyd J, Pawlik T. Advances in the diagnosis and treatment of patients with intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2020, 27(2): 552-560. [10] Nathan H, Pawlik T, Wolfgang C, et al. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis[J]. J Gastrointest Surg, 2007, 11(11): 1488-1496; discussion 1496-1497. [11] Ribero D, Pinna A, Guglielmi A, et al. Surgical approach for long-term srvival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients[J]. Arch Surg, 2012, 147(12): 1107-1113. [12] Nathan H, Aloia T, Vauthey J, et al. A proposed staging system for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2009, 16(1): 14-22. [13] Spolverato G, Vitale A, Cucchetti A, et al. Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?[J]. Cancer, 2015, 121(22): 3998-4006. [14] Chan K, Tsai C, Yeh C, et al. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence[J]. BMC Gastroenterol, 2018, 18(1): 180. [15] 季鸿翔, 司马辉, 匡悦, 等. 肝内胆管癌根治性切除术中淋巴结清扫价值研究[J]. 中国实用外科杂志, 2020, 40(6): 703-709. JI Hongxiang, SI Mahui, KUANG Yue, et al. Significance of lymphadenectomy in intrahepatic cholangiocarcinoma with radical resection[J]. Chinese Journal of Practical Surgery, 2020, 40(6): 703-709. [16] Spolverato G, Ejaz A, Kim Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2014, 18(7): 1284-1291. [17] Koprowski H, Steplewski Z, Mitchell K, et al. Colorectal carcinoma antigens detected by hybridoma antibodies[J]. Somatic cell genetics, 1979, 5(6): 957-971. [18] Liang B, Zhong L, He Q, et al. Diagnostic accuracy of serum CA19-9 in patients with cholangiocarcinoma: a systematic review and meta-analysis[J]. Med Sci Monit, 2015, 21: 3555-3563. doi: 10.12659/msm.895040. [19] Yamada T, Nakanishi Y, Okamura K, et al. Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma[J]. J Gastroenterol Hepatol, 2018, 33(9): 1626-1633. [20] Bergquist J, Ivanics T, Storlie C, et al. Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis[J]. J Surg Oncol, 2016, 114(4): 475-482. [21] Yang H, Wang J, Li Z, et al. Risk factors and outcomes of early relapse after curative resection of intrahepatic cholangiocarcinoma[J]. Front Oncol, 2019, 9: 854. doi: 10.3389/fonc.2019.00854. [22] Addeo P, Jedidi I, Locicero A, et al. Prognostic impact of tumor multinodularity in intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2019, 23(9): 1801-1809. [23] Hyder O, Marques H, Pulitano C, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience[J]. JAMA Surgery, 2014, 149(5): 432-438. [24] Okubo S, Mitsunaga S, Kato Y, et al. The prognostic impact of differentiation at the invasive front of biliary tract cancer[J]. J Surg Oncol, 2018, 117(6): 1278-1287. [25] Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy[J]. J Clin Oncol, 2013, 31(9): 1188-1195. |
[1] | GAO Zhongxia, ZHANG Ming, FAN Mingde, TAN Chenyang, WANG Mengdi, WANG Chao, FAN Yuefei, DING Shouluan, WANG Chengwei. Efficacy and prognostic factors of gamma knife in treating 81 cases of brain metastases from lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 44-49. |
[2] | YANG Lizhi, SUN Xiao, SHANG Mengmeng, GUO Lu, SHI Dandan, LI Jie. C-TIRADS-based nomogram for malignant risk prediction of thyroid nodules [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 64-69. |
[3] | YUAN Hongtao, JI Congshan, KANG Bing, QIN Songnan, YU Xinxin, GAO Lin, WANG Ximing. Diagnostic value of CT radiomics nomogram for adrenal lipid-poor adenoma and nodular hyperplasia [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 68-75. |
[4] | ZUO Liping, JIANG Fengyang, ZHOU Binbin, FAN Jinlei, LIANG Yongfeng, DENG Zhanhao, YU Dexin. Value of preoperative multiphase MRI for predicting microvascular invasion and early recurrence of 169 hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 89-95. |
[5] | Lixiao CHEN,Xinjiang YING,Xinwei CHEN,Fei WANG,Zhenfeng SUN,Pin DONG. Identification of proteins in hypopharyngeal squamous cell carcinoma by mass spectrometry and screening of prognostic target molecules [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 140-147. |
[6] | MAO Qian, WANG Zhe, GUAN Peixia, LIU Yujie, XIAO Yufei, YANG Yi, CONG Huiwen,WANG Lianyuan, SHI Fuyan, WANG Suzhen. Correlation analysis of dynamic changes of uric acid and incidence of gout in 1,144 cases [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 107-112. |
[7] | LAN Hongtao, JIA Xu, TONG Zhoujie, ZHENG Man, HU Boang, ZHONG Ming, ZHANG Wei, WANG Zhihao. Readmission prediction of 152 non-selective adult patients with chronic heart failure [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 63-69. |
[8] | SONG Zhenzhen, SUN Xiaoling, LI Haiou, WANG Fang, ZHANG Ran, YU Dexin. Value of MRI radiomics of glioma and peritumoral edema in evaluating tumor recurrence [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 53-60. |
[9] | WU Mengtao, WU Peng, YANG Yanfei, TANG Dianjun, MIAO Xiangling, LI Fandong. Application of CT venography in the diagnosis and treatment of recurrent lower extremity varicose veins [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 21-26. |
[10] | XIAO Yufei, FENG Jianing, WANG Xiaoxuan, MAO Qian, SHI Fuyan, WANG Suzhen. Prediction of the prognosis of 312 cirrhosis patients using the joint models and database [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 71-76. |
[11] | CHEN Linlin, YI Shaolei, WANG Weizong, LI Zhan, ZHANG Yong, ZHANG Yujiao,REN Manyi, XIE Xinxing, LIU Tongbao, HOU Yinglong. Risk factors of recurrent atrial fibrillation after radiofrequency catheter ablation [J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 49-57. |
[12] | LI Fan, SHAO Jianhua, ZHAO Hongyu, DOU Chunhui, LÜ Yahui, LI Daqi. Clinical features and prognosis of adult secondary hemophagocytic syndrome: an analysis of 32 cases [J]. Journal of Shandong University (Health Sciences), 2019, 57(12): 62-67. |
[13] | WANG Jinhui, YANG Jiaxin, YUAN Zhen, CAO Dongyan, SHEN Keng, HUANG Huifang, WU Ming, PAN Lingya, GUO Lina. Preserve fertility in recurrent and uncontrolled malignant ovarian germ cell tumors [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 35-40. |
[14] | ZHOU Huimei, YANG Jiaxin, CAO Dongyan, SHEN Keng, XIANG Yang, WU Ming, PAN Lingya, HUANG Huifang, LANG Jinghe. Fertility-sparing radical trachelectomy for young women with early stage cervical cancer: surgical and obstetrical outcomes [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 18-22. |
[15] | YU Mei, YANG Jiaxin, CAO Dongyan, WANG Yao, SHEN Keng. Diagnosis and management in patients with recurrent stage I endometrial cancer after primary fertility-preserving treatment [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 23-29. |
|